TY  - JOUR

T1  - A cost-effectiveness analysis of remdesivir for the treatment of hospitalised patients with COVID-19 in England and Wales

JO  - Value in Health

UR  - https://eprints.whiterose.ac.uk/182703/

PY  - 2022/02/20

AU  - Rafia R

AU  - Martyn-St James M

AU  - Harnan S

AU  - Metry A

AU  - Hamilton J

AU  - Wailoo A

ED  - 

DO  - DOI: 10.1016/j.jval.2021.12.015

PB  - Elsevier

Y2  - 2024/10/22

ER  -